Design: Real-world analysis of commercial claims data against an interaction database
Population: 100 most-prescribed drugs among US adults and adolescents with sickle cell disease
Primary outcome: Proportion of drugs with drug-drug interaction risk and the mechanisms involved
Effect: 43/100 drugs carried DDI risk; CYP3A4 predominant; oxycodone 40%, fentanyl 18.5% prescribed

People with sickle cell disease take many drugs — for the disease, for pain, and for its complications — yet no consolidated map of their interaction risk existed. This analysis took the 100 most-prescribed drugs in a large US commercial claims database of people with sickle cell disease and checked them against an interaction database.

Forty-three of the 100 carried interaction risk, driven more by enzyme inhibition than induction, and CYP3A4 accounted for the largest share. The standout hazard is opioids: oxycodone (prescribed to 40%) and fentanyl (18.5%) are CYP3A4 substrates, so a co-prescribed CYP3A4 inhibitor can raise opioid levels into dangerous territory.

Sickle cell disease is common in central and tribal India, where pain management leans on opioids and polypharmacy is routine. The practical message is to treat a new CYP3A4 inhibitor in a patient on oxycodone or fentanyl as a reason to reconsider the opioid dose, and to screen the whole regimen when adding any drug.

Nearly half of the most-prescribed sickle cell drugs carried drug-interaction risk.
CYP3A4 was the commonest mechanism, and inhibition outweighed induction.
Oxycodone and fentanyl, both CYP3A4 substrates, are widely prescribed and interaction-prone.
Reconsider the opioid dose when adding a CYP3A4 inhibitor in these patients.

Why it matters

It maps a real interaction burden in a polypharmacy-heavy group and points to the opioid–CYP3A4 combination as the dangerous one.

The statistics, in plain English

These are potential interactions flagged by a database from prescription frequencies, not observed harms, so they indicate where to look rather than how often harm occurred.